84
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Infliximab administration reduces neuronal apoptosis on the optic pathways in a rabbit hydrocephalus Model: A preliminary report

, , , , , & show all
Pages 290-294 | Received 29 Aug 2009, Accepted 25 Jan 2010, Published online: 14 May 2010

References

  • Prins ML, Lee SM, Cheng CL, et al Fluid percussion brain injury in the developing and adult rat: a comparative study of mortality, morphology, intracranial pressure and mean arterial blood pressure. Brain Res Dev Brain Res 1996;95:272–282.
  • Del Bigio MR. Neuropathological changes caused by hydrocephalus. Acta Neuropathol 1993;85:573–585.
  • McAllister JP 2nd, Chovan P. Neonatal hydrocephalus. Mechanisms and consequences. Neurosurg Clin N Am 1998;9:73–93.
  • Tracey KJ. Tumor necrosis factor-alpha. The cytokine handbook, in Thomson AW, vol. 19. 2nd ed. London: Academic Press; 1994: 343–369.
  • Lieberman AP, Pitha PM, Shin HS, Shin ML. Production of tumor necrosis factor and other cytokines by astrocytes stimulated with lipopolysaccharide or a neurotropic virus. Proc Natl Acad Sci U S A 1989;86:6348–6352.
  • Righi M, Mori L, De Libero G, et al Monokine production by microglial cell clones. Eur J Immunol 1989;19:1443–1448.
  • Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988;23:339–346.
  • D'Souza S, Alinauskas K, McCrea E, et al Differential susceptibility of human CNS-derived cell populations to TNF-dependent and independent immune-mediated injury. J Neurosci 1995;15:7293–7300.
  • McLaurin J, D'Souza S, Stewart J, et al Effect of tumor necrosis factor alpha and beta on human oligodendrocytes and neurons in culture. Int J Dev Neurosci 1995;13:369–381.
  • Davis PC, Mirra SS, Alazraki N. The brain in older persons with and without dementia: findings on MR, PET, and SPECT images. AJR Am J Roentgenol 1994;162:1267–1278.
  • Bang LM, Keating GM. Adalimumab: a review of its use in rheumatoid arthritis. BioDrugs 2004;18:121–139.
  • Tak PP. Effects of infliximab treatment on rheumatoid synovial tissue. J Rheumatol Suppl 2005;74:31–34.
  • van der Heijde D, Dijkmans B, Geusens P, et al Ankylosing Spondylitis Study for the Evaluation of Recombinant Infliximab Therapy Study Group. Efficacy and safety of infliximab in patients with ankylosing spondylitis: results of a randomized, placebo-controlled trial (ASSERT). Arthritis Rheum 2005;52:582–591.
  • Sandborn WJ. New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord 2005;5:10–18.
  • Kleinert J, Lorenz M, Köstler W, et al Refractory Wegener's granulomatosis responds to tumor necrosis factor blockade. Wien Klin Wochenschr 2004;116:334–338.
  • Hellmich B, Lamprecht P, Gross WL. Advances in the therapy of Wegener's granulomatosis. Curr Opin Rheumatol 2006;18:25–32.
  • Li J, McAllister JP 2nd, Shen Y, et al Communicating hydrocephalus in adult rats with kaolin obstruction of the basal cisterns or the cortical subarachnoid space. Exp Neurol 2008;211:351–361.
  • Elisevich KV, Ford RM, Anderson DP, et al Visual abnormalities with multiple trauma. Surg Neurol 1984;22:565–575.
  • Kane NM, Moss TH, Curry SH, Butler SR. Quantitative electroencephalographic evaluation of non-fatal and fatal traumatic coma. Electroencephalogr Clin Neurophysiol 1998;106:244–250.
  • Caner H, Atasever A, Kilinç K, et al Lipid peroxide level increase in experimental hydrocephalus. Acta Neurochir (Wien) 1993;121:68–71.
  • Akai K, Uchigasaki S, Tanaka U, Komatsu A. Normal pressure hydrocephalus. Neuropathological study. Acta Pathol Jpn 1987;37:97–110.
  • Miyagami M, Shibuya T, Tsubokawa T. Subependymal CSF absorption in hydrocephalic edema. in Matsumoto S, Tamaki N, Hydrocephalus, pathogenesis and treatment. Tokyo: Springer Verlag; 1981: 181–194.
  • Weller RO, Wiśniewski H, Shulman K, Terry RD. Experimental hydrocephalus in young dogs: histological and ultrastructural study of the brain tissue damage. J Neuropathol Exp Neurol 1971;30:613–626.
  • Socci DJ, Bjugstad KB, Jones HC, et al Evidence that oxidative stress is associated with the pathophysiology of inherited hydrocephalus in the H-Tx rat model. Exp Neurol 1999;155:109–117.
  • Rosenberg GA, Saland L, Kyner WT. Pathophysiology of periventricular tissue changes with raised CSF pressure in cats. J Neurosurg 1983;59:606–611.
  • Higashi K, Asahisa H, Ueda N, et al Cerebral blood flow and metabolism in experimental hydrocephalus. Neurol Res 1986;8:169–176.
  • Del Bigio MR, Bruni JE. Changes in periventricular vasculature of rabbit brain following induction of hydrocephalus and after shunting. J Neurosurg 1988;69:115–120.
  • Mori K, Miyake H, Kurisaka M, Sakamoto T. Immunohistochemical localization of superoxide dismutase in congenital hydrocephalic rat brain. Childs Nerv Syst 1993;9:136–141.
  • Miller JM, McAllister JP 2nd. Reduction of astrogliosis and microgliosis by cerebrospinal fluid shunting in experimental hydrocephalus. Cerebrospinal Fluid Res 2007;4:5.
  • Streit WJ, Semple-Rowland SL, Hurley SD, et al Cytokine mRNA profiles in contused spinal cord and axotomized facial nucleus suggest a beneficial role for inflammation and gliosis. Exp Neurol 1998;152:74–87.
  • Genovese T, Mazzon E, Crisafulli C, et al TNF-alpha blockage in a mouse model of SCI: evidence for improved outcome. Shock 2008;29:32–41.
  • Tarkowski E, Tullberg M, Fredman P, Wikkelsö C. Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. Neurobiol Aging 2003;24:707-714.
  • Harrington JF, Messier AA, Levine A, et al Shedding of tumor necrosis factor type 1 receptor after experimental spinal cord injury. J Neurotrauma 2005;22:919–928.
  • Davidsson P, Fredman P, Månsson JE, Svennerholm L. Determination of gangliosides and sulfatide in human cerebrospinal fluid with a microimmunoaffinity technique. Clin Chim Acta 1991;197:105–115.
  • Davies L, McLeod JG, Muir A, Hensley WJ. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness. Clin Exp Neurol 1987;24:5–10.
  • Deo-Narine V, Gomez DG, Vullo T, et al Direct in vivo observation of transventricular absorption in the hydrocephalic dog using magnetic resonance imaging. Invest Radiol 1994;29:287–293.
  • Fredman P, Wallin A, Blennow K, et al Sulfatide as a biochemical marker in cerebrospinal fluid of patients with vascular dementia. Acta Neurol Scand 1992;85:103–106.
  • Godersky JC, Graff-Radford NR, Yuh WT. Magnetic resonance imaging of patients with normal pressure hydrocephalus. Adv Neurol 1990;52:554.
  • Graff-Radford NR, Rezai K, Godersky JC, et al Regional cerebral blood flow in normal pressure hydrocephalus. J Neurol Neurosurg Psych 1987;50:1589–1596.
  • Gupta MK. Myelin basic protein and demyelinating diseases. Crit Rev Clin Lab Sci 1987;24:287–314.
  • Kurt G, Ergün E, Cemil B, et al Neuroprotective effects of infliximab in experimental spinal cord injury. Surg Neurol 2009;71:332–336.
  • Yinon U, Chen M, Milgram A. Hydrocephalus in developing cats: physiological properties of visual cortex cells. Brain Res Bull 1990;25:651–663.
  • Genovese T, Mazzon E, Esposito E, et al Effect of thalidomide on signal transduction pathways and secondary damage in experimental spinal cord trauma. Shock 2008;30:231–240.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.